Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DEVICE: Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort|DEVICE: Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
Sponsor: Boston Medical Center
Collaborators: American Cancer Society, Inc.